← Leaderboards
Timothy L Denning
Georgia State University
$5,827,532
Attributed
$7,930,651
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–23$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,930,651 · 11
By mechanism
R01$6,467,653 · 4
R00$732,455 · 1
R21$426,250 · 1
P51$219,254 · 4
K99$85,039 · 1
Top collaborators
- Didier Merlin9 shared
- Andrew T Gewirtz4 shared
- Charles A Parkos2 shared
Most similar at Georgia State University
Same institution · by research overlap
- Andrew T Gewirtz$16,795,822
Others in their field
Top investigators on “Intestines”
- Richard S Blumberg · Children'S Hospital Boston$45,768,173
- Mark Donowitz · Johns Hopkins University$37,125,295
- Israel David Goldman · Yeshiva University$32,031,336
- Samuel A Wells · Duke University$31,864,469
- Margaret Rita Karagas · Dartmouth College$30,262,431
- Abhik Das · Research Triangle Institute$30,240,510
Research focus
IntestinesInflammatoryInflammatory Disease Of The IntestineColitisCellsMacrophageIn VivoIn VitroInflammationResponseInvestigationAntigen-Presenting CellsDendritic CellsRegulatory T-LymphocytePathogenesisCytokineChronicAcuteImmune ResponseT-LymphocyteAnti-Inflammatory AgentsInflammatory Bowel DiseasesLamina PropriaMouse Model
Grant awards (28)
IL-36 cytokines and gut immunity$418,805
R01 · FY2023 · DK · contact PI
IL-36 cytokines and gut immunity$418,805
R01 · FY2022 · DK · contact PI
IL-36 cytokines and gut immunity$418,023
R01 · FY2021 · DK · contact PI
Fecal exosomes as a source of miRNA biomarkers for diagnosing the degree of colitis and as a drug delivery system to reduce colitis$445,024
R01 · FY2020 · DK
IL-36 cytokines and gut immunity$415,897
R01 · FY2020 · DK · contact PI
Novel Therapeutic Approaches For Treatment of Intestinal Inflammation$340,875
R01 · FY2020 · DK
Fecal exosomes as a source of miRNA biomarkers for diagnosing the degree of colitis and as a drug delivery system to reduce colitis$445,024
R01 · FY2019 · DK
Novel Therapeutic Approaches For Treatment of Intestinal Inflammation$348,047
R01 · FY2019 · DK
Fecal exosomes as a source of miRNA biomarkers for diagnosing the degree of colitis and as a drug delivery system to reduce colitis$445,024
R01 · FY2018 · DK
Novel Therapeutic Approaches For Treatment of Intestinal Inflammation$340,875
R01 · FY2018 · DK
Novel Therapeutic Approaches For Treatment of Intestinal Inflammation$35,855
R01 · FY2018 · DK
Fecal exosomes as a source of miRNA biomarkers for diagnosing the degree of colitis and as a drug delivery system to reduce colitis$445,024
R01 · FY2017 · DK
Novel Therapeutic Approaches For Treatment of Intestinal Inflammation$340,875
R01 · FY2017 · DK
Intestinal Antigen Presenting Cells and Mucosal Immunity$321,900
R01 · FY2017 · DK · contact PI
Intestinal Antigen Presenting Cells and Mucosal Immunity$321,900
R01 · FY2016 · DK · contact PI
Intestinal Antigen Presenting Cells and Mucosal Immunity$321,900
R01 · FY2015 · DK · contact PI
Intestinal Antigen Presenting Cells and Mucosal Immunity$321,900
R01 · FY2014 · DK · contact PI
Intestinal Antigen Presenting Cells and Mucosal Immunity$321,900
R01 · FY2013 · DK · contact PI
Regulation of Mucosal Immune Responses by Intestinal Antigen Presenting Cells$236,945
R00 · FY2011 · AA · contact PI
Regulation of Mucosal Immune Responses by Intestinal Antigen Presenting Cells$246,510
R00 · FY2010 · AA · contact PI
The Role of Jam-A in Regulating Intestinal Antigen Presenting Cell Function and I$232,500
R21 · FY2010 · AI · contact PI
THE ROLE OF ANTIGEN PRESENTING CELLS IN MODULATING INTESTINAL IMMUNE RESPONSES$54,827
P51 · FY2010 · RR · contact PI
REGULATION OF MUCOSAL IMMUNE RESPONSES BY ANTIGEN PRESENTING CELLS$54,827
P51 · FY2010 · RR · contact PI
Regulation of Mucosal Immune Responses by Intestinal Antigen Presenting Cells$249,000
R00 · FY2009 · AA · contact PI
The Role of Jam-A in Regulating Intestinal Antigen Presenting Cell Function and I$193,750
R21 · FY2009 · AI · contact PI
THE ROLE OF ANTIGEN PRESENTING CELLS IN MODULATING INTESTINAL IMMUNE RESPONSES$54,800
P51 · FY2009 · RR · contact PI
REGULATION OF MUCOSAL IMMUNE RESPONSES BY ANTIGEN PRESENTING CELLS$54,800
P51 · FY2009 · RR · contact PI
Regulation of Mucosal Immune Responses by Intestinal Antigen Presenting Cells$85,039
K99 · FY2008 · AA · contact PI